These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis. du Plessis M. Diagn Microbiol Infect Dis; 2001 Jan; 39(1):65-7. PubMed ID: 11173194 [Abstract] [Full Text] [Related]
12. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan. Ikeda F, Yokota Y, Mine Y, Yamada T. Chemotherapy; 1993 Jan; 39(2):88-95. PubMed ID: 8458251 [Abstract] [Full Text] [Related]
16. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis? Pottumarthy S, Sader HS, Fritsche TR, Jones RN. Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168 [Abstract] [Full Text] [Related]